Onilcamotide
Onilcamotide is a synthetic peptide cancer vaccine derived from the RhoC protein's C-terminal region. It demonstrates immunomodulatory and antineoplastic properties, showing potential in preclinical research for inhibiting tumor metastasis in both in vitro and in vivo experimental models.
Product Specifications
Molecular Weight
2293.78
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog